HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1403171Generated: November 4, 2026
2-Methoxyethylamine → HCID 178496027, compound
https://huagongshe.com/reaction/1403171
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | 2-Methoxyethylamine | HCID 8018 | — |
| Reactant | Diisopropylethylamine | HCID 81531 | — |
| Reactant | HCID 86686819 | HCID 86686819 | — |
| Reactant | HCID 178525774 | HCID 178525774 | — |
| Solvent | Water | HCID 962 | — |
| Solvent | Chloroform | HCID 6212 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | HCID 178496027 | HCID 178496027 | 44.6% |
Reaction Steps
To a 2-methoxyethanamine (1.9 mg) were added a solution of trans-4-({6-[2-(difluoromethyl)-1H-benzimidazol-1-yl]-2-(morpholin-4-yl)pyrimidin-4-yl}oxy)cyclohexanecarboxylic acid (11.8 mg) and N,N-diisopropylethylamine (10.5 μL) in N,N-dimethylformamide (400 μL), and were added a solution of N-[(dimethylamino)(3H-[1,2,3]triazolo[4,5-b]pyridin-3-yloxy)methylene]-N-methylMethanaminium hexafluorophosphoric acid (11.4 mg) in N,N-dimethylformamide (100 μL), followed by stirring at room temperature overnight. To the reaction solution were added water and chloroform, followed by liquid separation, and the organic layer was concentrated under reduced pressure. The residue was subjected to preparative purification with HPLC to obtain trans-4-({6-[2-(difluoromethyl)-1H-benzimidazol-1-yl]-2-(morpholin-4-yl)pyrimidin-4-yl}oxy)-N-(2-methoxyethyl)cyclohexanecarboxamide (5.9 mg).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08912180B2 |
|---|
| Source dataset | uspto-grants-2014_12 |
|---|
| ORD ID | ord-b8a989c11bcf4c7ebb11c69ec2a2d366 |
|---|
| Source note | uspto-grants-2014_12 |
|---|